Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations.
Publication
, Journal Article
Newby, LK; Alpert, JS; Ohman, EM; Thygesen, K; Califf, RM
Published in: Am Heart J
December 2002
Duke Scholars
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
December 2002
Volume
144
Issue
6
Start / End Page
957 / 980
Location
United States
Related Subject Headings
- United States
- Troponin
- Sensitivity and Specificity
- Prognosis
- Necrosis
- Myocardium
- Myocardial Infarction
- Isoenzymes
- Humans
- Health Policy
Citation
APA
Chicago
ICMJE
MLA
NLM
Newby, L. K., Alpert, J. S., Ohman, E. M., Thygesen, K., & Califf, R. M. (2002). Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. Am Heart J, 144(6), 957–980. https://doi.org/10.1067/mhj.2002.129778
Newby, L Kristin, Joseph S. Alpert, E Magnus Ohman, Kristian Thygesen, and Robert M. Califf. “Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations.” Am Heart J 144, no. 6 (December 2002): 957–80. https://doi.org/10.1067/mhj.2002.129778.
Newby LK, Alpert JS, Ohman EM, Thygesen K, Califf RM. Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. Am Heart J. 2002 Dec;144(6):957–80.
Newby, L. Kristin, et al. “Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations.” Am Heart J, vol. 144, no. 6, Dec. 2002, pp. 957–80. Pubmed, doi:10.1067/mhj.2002.129778.
Newby LK, Alpert JS, Ohman EM, Thygesen K, Califf RM. Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. Am Heart J. 2002 Dec;144(6):957–980.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
December 2002
Volume
144
Issue
6
Start / End Page
957 / 980
Location
United States
Related Subject Headings
- United States
- Troponin
- Sensitivity and Specificity
- Prognosis
- Necrosis
- Myocardium
- Myocardial Infarction
- Isoenzymes
- Humans
- Health Policy